Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2019-01-11 Regulatory Filings
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
Publication of VAL401 peer-reviewed article
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated January 11, 2019. The content announces the 'Publication of article in the 'European Journal of Drug Metabolism and Pharmacokinetics'' regarding clinical trial results for VAL401. This is a short announcement (3932 characters) whose primary purpose is to inform the market that a specific piece of information (a journal article) has been published and provides a link to it. According to Rule 2 (The 'MENU VS MEAL' Rule), when a document is short and announces the publication of external material, it should be classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since this is a specific announcement about the publication of research findings via the RNS system, RPA is the most precise fit, as it announces the release of information, rather than being the detailed financial report itself.
2019-01-11 English
ValiRx endorses the Government's new NHS strategy
Environmental & Social Information Classification · 1% confidence The document begins with an 'RNS Number' and is dated January 9, 2019. The content is a brief press release where ValiRx Plc endorses the Government's new NHS strategy, focusing on personalized therapeutics and early diagnostics. It is not a comprehensive financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). It is a general corporate announcement distributed via the London Stock Exchange's news service (RNS). Since it is a general, non-specific regulatory announcement that doesn't fit the other defined categories (like DIRS, DIV, CAP, etc.), the most appropriate fallback category is Regulatory Filings (RNS). The document length is short (4185 chars), but it is the primary announcement itself, not an announcement *about* another report, so RPA is less suitable than RNS for this type of general news update.
2019-01-09 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly identified by the header 'RNS Number : 0072M' and contains the standard structure for a 'NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)'. This form details changes in voting rights thresholds crossed by a shareholder (Nicholas Slater) in ValiRx Plc. This type of filing, which reports changes in significant share ownership, directly corresponds to the Major Shareholding Notification category. The presence of 'RNS Number' and the reference to the FCA confirms it is a regulatory filing, but the specific content points to MRQ rather than the general RNS fallback.
2019-01-03 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1495 characters) and contains an RNS Number (8885K), indicating it is a regulatory announcement from the London Stock Exchange. The content discusses a 'Second Price Monitoring Extension' for a security, which is a specific operational notice related to trading halts or volatility controls. This type of miscellaneous, non-standard regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory filing category.
2018-12-18 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1478 characters) and contains an 'RNS Number' header, indicating it is a regulatory news service announcement from the London Stock Exchange. The content specifically discusses a 'Price Monitoring Extension' for a security, which is a routine operational update related to trading mechanisms, not a core financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, CAP, MANG). Since this is a general regulatory announcement that doesn't fit into the more specific categories (like DIRS, DVA, DLST, etc.), the most appropriate classification is the general fallback category for miscellaneous regulatory filings, which is 'Regulatory Filings' (RNS).
2018-12-18 English
Issue of Equity / PDMR Shareholdings
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 8428K' and contains information typical of a regulatory news service announcement from the London Stock Exchange (LSE). The content details an 'Issue of Equity', director participation ('PDMR Shareholdings'), and a 'Related Party Transaction'. The presence of the RNS number, the explicit mention of RNS at the end, and the nature of the announcement (a specific corporate action update) strongly indicate this is a regulatory filing disseminated via the RNS system. While it involves share issuance (SHA) and director dealings (DIRS), the primary classification for a general, time-sensitive regulatory announcement distributed through the LSE's official news service, especially when it doesn't fit neatly into the major periodic reports (10-K, IR), is RNS.
2018-12-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.